Kamakura, Japan

Joonsik Park

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Toray Industries, Inc.. Active years: 2014-2020.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joonsik Park

Introduction

Joonsik Park is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of 2 patents, Park continues to push the boundaries of scientific research and application.

Latest Patents

One of Joonsik Park's latest patents is an immunopotentiator that comprises a modified β-glucan as an active ingredient. This immunopotentiator enhances the immunopotentiating effect of β-glucan, showcasing its potential in medical applications. Another significant patent is a water-soluble polymer and water-soluble nanoparticle composite. This invention features a water-soluble nanoparticle complex that exhibits excellent uniformity and stability, allowing for effective use of nanoparticles in biochemical applications.

Career Highlights

Joonsik Park is currently associated with Toray Industries, Inc., where he applies his expertise in developing innovative solutions. His work at Toray Industries has positioned him as a key player in the advancement of biotechnology.

Collaborations

Throughout his career, Park has collaborated with talented individuals such as Asako Sogame and Masashi Higasa. These collaborations have further enriched his research and development efforts.

Conclusion

Joonsik Park's contributions to biotechnology through his patents reflect his dedication to innovation and scientific advancement. His work continues to inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…